Niagen Bioscience, Inc. share price logo

Niagen Bioscience, Inc.

NASDAQ: NAGE

Small Cap

$3.37

-0.08

(-2.32%)

as on

Niagen Bioscience, Inc. Stock Performance

as on June 9, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $3.35
    $3.50
    downward going graph

    0.59%

    Downside

    3.86%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.35
    $14.69
    downward going graph

    0.59%

    Downside

    335.91%

    Upside

    downward going graph

Niagen Bioscience, Inc. share price movements today

Previous Close
$3.45
Open
$3.47
Volume
618.1K
Day's Low - High
$3.35 - $3.50
52 Week Low - High
$3.35 - $14.69

Niagen Bioscience, Inc. Historical Returns

1 Month Return
-19.18 %
3 Month Return
-34.05 %
1 Year Return
-74.91 %
3 Year Return
0 %
5 Year Return
0 %

Niagen Bioscience, Inc. Stock Fundamentals & Key Indicators

Check Niagen Bioscience, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$274.8M

EPS (TTM)

0.23

Dividend Yield

0.00%

PE Ratio (TTM)

16.43

Industry PE ratio

-3.8021729490022174

PEG Ratio

0

Return On Equity TTM

27.07%

Niagen Bioscience, Inc. Stock Valuation

Track how Niagen Bioscience, Inc. P/E has moved over time to understand its valuation trends.

Niagen Bioscience, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (28.78x)

March 31, 2026

Industry (-3.80x)

June 9, 2026

Today (16.43x)

June 9, 2026

Highest (49.37x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 16.43x

Niagen Bioscience, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Niagen Bioscience, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Niagen Bioscience, Inc. image
Niagen Bioscience, Inc.
NA$274.8MNA16.4314.29%NA
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.5B85.6%76.3312.55%NA
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$113.4B107.42%26.5235.51%NA
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$66.6B17.15%15.529.65%0.5700000000000001%

Stock Returns calculator for Niagen Bioscience, Inc. Stock including INR - Dollar returns

The Niagen Bioscience, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Niagen Bioscience, Inc. investment value today

Current value as on today

₹28,033

Returns

-₹71,967

(-71.97%)

Returns from Niagen Bioscience, Inc. Stock

-₹74,907 (-74.91%)

Dollar Impact

₹2,940 (+2.94%)

Indian Investors' Interest in Niagen Bioscience, Inc. Stock

Search interest for Niagen Bioscience, Inc. Stock has increased by 76% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:76% versus previous 30 day period

Niagen Bioscience, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
21
22
22
25
29
30
31
33
33
31
Gross Profit
12
13
13
16
18
19
20
21
21
19
Operating Income
0
0
0
1
7
4
3
4
2
1
EBITDA
0
0
0
1
7
5
3
4
2
1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
0
1
7
5
3
4
4
6
Income Tax Expense
-
-
-
-
0
0
0
0
0
0
Net Income
0
0
0
1
7
5
3
4
4
6
Net Profit Margin
0.54%
-2.22%
-0.07%
7.34%
24.65%
16.61%
11.60%
13.47%
12.21%
20.07%

Niagen Bioscience, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
21
21
31
46
59
67
72
83
99
129
Gross Profit
10
10
16
25
35
41
42
50
61
83
Operating Income
-2
-16
-33
-31
-19
-27
-18
-5
7
14
EBITDA
-2
-15
-32
-29
-18
-25
-16
-3
9
15
Interest Expense
0
0
0
0
0
0
-
-
-
-
Depreciation
-
-
-
-
-
1
1
1
1
1
Income Before Tax
-3
-16
-33
-32
-19
-27
-16
-4
8
18
Income Tax Expense
-
-
-
-
-
-
-
-
0
0
Net Income
-2
-11
-33
-32
-19
-27
-16
-4
8
17
Net Profit Margin
-13.52%
-53.67%
-105.57%
-69.45%
-33.62%
-40.22%
-22.96%
-5.91%
8.58%
13.43%

Niagen Bioscience, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
0
0
1
7
5
3
4
4
6
Operating Cash Flow
0
0
3
8
7
1
3
0
-1
Investing Cash Flow
0
0
0
0
0
0
0
0
5
Financing Cash Flow
0
0
1
3
3
3
0
0
-2
Change in Cash
0
0
4
12
10
4
3
0
1

Niagen Bioscience, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-11
-33
-32
-19
-27
-16
-4
8
17
Operating Cash Flow
-9
-20
-20
-10
-24
-15
7
12
13
Investing Cash Flow
4
-1
0
0
0
0
0
0
0
Financing Cash Flow
48
0
16
8
36
7
0
5
6
Change in Cash
43
-22
-3
-2
11
-7
6
17
20

Global Institutional Holdings in Niagen Bioscience, Inc.

Funds
Holdings
Arrowstreet Capital Limited Partnership
2.99%
Vanguard Capital Management, LLC
2.7%
Charles Schwab Investment Management Inc
0.56%
Tieton Capital Management, LLC
2.55%
Nuveen, LLC
0.62%
See all

Insights on Niagen Bioscience, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NAGE has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 4.13M → 6.31M (in $), with an average increase of 34.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.1% return, outperforming this stock by 93.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 33.98M → 31.47M (in $), with an average decrease of 3.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, NAGE stock has moved down by -34.1%

About Niagen Bioscience, Inc.

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
OrganisationNiagen Bioscience, Inc.
Headquarters10900 Wilshire Blvd, Los Angeles, CA, United States, 90024
IndustryBiotechnology
CEOMr. Robert N. Fried
E-voting on sharesClick here to vote

Key Management of Niagen Bioscience, Inc.

Name

Title

Kendall Knysch

Head of Media Relations & Partnerships

Mr. James Lee

Controller

Ms. Chu Yan

Managing Director of Asia Pacific

Wesley Yu

Vice President of Finance

Mr. Frank Louis Jaksch Jr.

Co-Founder & Chairman

Mr. Robert N. Fried

CEO & Director

Mr. Ozan Pamir C.F.A.

CFO & Principal Accounting Officer

Mr. Carlos Lopez

Senior VP & General Counsel

Dr. Andrew Shao Ph.D.

Senior Vice President of Global Regulatory & Scientific Affairs

Ms. Michiko Kelley

Chief Marketing Officer

FAQs

What is Niagen Bioscience, Inc. share price today?

Niagen Bioscience, Inc. share price today is $3.37 as on at the close of the market. Niagen Bioscience, Inc. share today touched a day high of $3.5 and a low of $3.35.

What is the 52 week high and 52 week low for Niagen Bioscience, Inc. share?

Niagen Bioscience, Inc. share touched a 52 week high of $14.69 on and a 52 week low of $3.35 on . Niagen Bioscience, Inc. stock price today i.e. is closed at $3.37,which is 77.06% down from its 52 week high and 0.60% up from its 52 week low.

What is Niagen Bioscience, Inc.'s market capitalisation today?

Niagen Bioscience, Inc. market capitalisation is $0.00T as on .

How to invest in Niagen Bioscience, Inc. Stock (NAGE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Niagen Bioscience, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Niagen Bioscience, Inc. Shares that will get you 0.4451 shares as per Niagen Bioscience, Inc. share price of $3.37 per share as on June 9, 2026 at 8:46 am IST.

What is the minimum amount required to buy Niagen Bioscience, Inc. Stock (NAGE) from India?

Indian investors can start investing in Niagen Bioscience, Inc. (NAGE) shares with as little as ₹95.7075 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.07 in Niagen Bioscience, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Niagen Bioscience, Inc. share’s latest price of $3.37 as on June 9, 2026 at 8:46 am IST, you will get 2.9674 shares of Niagen Bioscience, Inc.. Learn more about fractional shares .